1. A. D. Dangour, et al., “A randomised controlled trial investigating the effect of vitamin B12 supplementation on neurological function in healthy older people: the Older People and Enhanced Neurological function (OPEN) study protocol [ISRCTN54195799],” Nutr. J. 10:22. 22 (2011).

2. A. Gella, et al., “Effect of the nucleotides CMP and UMP on exhaustion in exercise rats,” J. Physiol Biochem. 64(1), 9 (2008).

3. D. Gong, et al., “Effect of pyrroloquinoline quinone on neuropathic pain following chronic constriction injury of the sciatic nerve in rats,” Eur. J. Pharmacol. 697(1-3), 53 (2012).

4. C. B. Harris, et al., “Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and itochondrial-related metabolism in human subjects,” J. Nutr. Biochem. 24(12), 2076 (2013).

5. B. He, et al., “[Effects of pyrroloquinoline quinine on oxidative stress-induced apoptosis of Schwann cells and its mechanism],” Zhonghua Zheng. Xing. Wai Ke. Za Zhi. 30(2), 111 (2014).

6. T. K. Lim, et al., “Mitochondrial and bioenergetic dysfunction in trauma-induced painful peripheral neuropathy,” Mol. Pain. 11:58. doi:10.1186/s12990-015-0057-7., 58 (2015).

7. Z. Liu, et al., “Pyrroloquinoline Quinone Decelerates Rheumatoid Arthritis Progression by Inhibiting Inflammatory Responses and Joint Destruction via Modulating NF-kappaB and MAPK Pathways,” Inflammation. 39(1), 248 (2016).

8. T. Martianez, et al., “UTP affects the Schwannoma cell line proteome through P2Y receptors leading to cytoskeletal reorganisation,” Proteomics. 12(1), 145 (2012).

9. L. Negrao, et al., “Effect of the combination of uridine nucleotides, folic acid and vitamin B12 on the clinical expression of peripheral neuropathies,” Pain Manag. 4(3), 191 (2014).

10. L. Negrao and P. Nunes, “Uridine monophosphate, folic acid and vitamin B12 in patients with symptomatic peripheral entrapment neuropathies,” Pain Manag. 6(1), 25 (2016).

11. M. Okada, et al., “Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats,” J. Pharmacol. Exp. Ther. 303(1), 66 (2002).

12. F. Scaglione and G. Panzavolta, “Folate, folic acid and 5-methyltetrahydrofolate are not the same thing,“ Xenobiotica. 44(5), 480 (2014).

13. R. Tao, et al., “Pyrroloquinoline Quinone Slows Down the Progression of Osteoarthritis by Inhibiting Nitric Oxide Production and Metalloproteinase Synthesis,” Inflammation. 38(4), 1546 (2015).

14. M. Tsuda, “P2 receptors, microglial cytokines and chemokines, and neuropathic pain,” J. Neurosci. Res. 10 (2016).

15. B. Wattig, et al., “Enhancement of nerve fibre regeneration by nucleotides after peripheral nerve crush damage. Electrophysiologic and morphometric investigations,”  Arzneimittelforschung. 42(9), 1075 (1992).

16. B. Wattig, et al., “Acceleration of nerve and muscle regeneration by administration of nucleotides–electroneurophysiological and morphometrical investigations,” Acta Histochem. Suppl. 42:333-9., 333 (1992).

17. C. Yang, et al., “Pyrroloquinoline quinone (PQQ) inhibits lipopolysaccharide induced inflammation in part via downregulated NF-kappaB and p38/JNK activation in microglial and attenuates microglia activation in lipopolysaccharide treatment mice,“ PLoS. One. 9(10), e109502 (2014).

18. A. A. Yousef and A. E. Al-deeb, “A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component,” Anaesthesia. 68(3), 260 (2013).